Race Oncology Ltd (RAC) — Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

Race Oncology Ltd (RAC) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (AU$570.64K) in capital expenditures (AU$4.00). Check Race Oncology Ltd (RAC) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

AU$570.64K
AUD

Capital Expenditures

AU$4.00
AUD

Data as of

Dec 2024
Most recent filing

Race Oncology Ltd Capital Reinvestment Ratio (2011–2013)

This chart tracks Race Oncology Ltd's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see RAC cash flow conversion.

Annual Capital Reinvestment Ratio for Race Oncology Ltd (2011–2013)

Year-by-year Capital Reinvestment Ratio for Race Oncology Ltd from 2011 to 2013. See Race Oncology Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2013 0.01x AU$3.71 Million AU$31.00K ▼ -74.4%
2012 0.03x AU$6.68 Million AU$218.00K ▲ +439.7%
2011 0.01x AU$11.92 Million AU$72.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow